Harmony Accounts Payable vs Capital Stock Analysis

HRMY Stock

USD 33.23 0.44 1.34%

Harmony Biosciences financial indicator trend analysis is much more than just examining Harmony Biosciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Harmony Biosciences is a good investment. Please check the relationship between Harmony Biosciences Accounts Payable and its Capital Stock accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Accounts Payable vs Capital Stock

Accounts Payable vs Capital Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Harmony Biosciences Accounts Payable account and Capital Stock. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Harmony Biosciences' Accounts Payable and Capital Stock is -0.53. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Capital Stock in the same time period over historical financial statements of Harmony Biosciences Holdings, assuming nothing else is changed. The correlation between historical values of Harmony Biosciences' Accounts Payable and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Harmony Biosciences Holdings are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Accounts Payable i.e., Harmony Biosciences' Accounts Payable and Capital Stock go up and down completely randomly.

Correlation Coefficient

-0.53

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Harmony Biosciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Harmony Biosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Most indicators from Harmony Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Harmony Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At this time, Harmony Biosciences' Tax Provision is fairly stable compared to the past year. Enterprise Value is likely to rise to about 1.9 B in 2024, whereas Selling General Administrative is likely to drop slightly above 60.8 M in 2024.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	18.8M	23.4M	24.3M	14.7M
Total Operating Expenses	162.4M	234.2M	268.8M	178.2M

Reconciled Depreciation Total Operating Expenses

Harmony Biosciences fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Non Current Liabilities Other	Net Working Capital
Total Assets		0.9	0.91	0.87	0.73	0.91	-0.95	-0.12	0.02	0.66	0.96	0.99	0.88	0.83	0.98	0.74	0.89	0.98	0.73	0.93	0.95	-0.94	0.99	-0.92	0.86	0.94
Other Current Liab	0.9		0.99	0.69	0.59	0.77	-0.86	-0.04	-0.17	0.61	0.91	0.9	0.68	0.65	0.88	0.68	0.88	0.82	0.84	0.95	0.86	-0.91	0.88	-0.89	0.66	0.73
Total Current Liabilities	0.91	0.99		0.72	0.59	0.78	-0.87	-0.07	-0.1	0.67	0.91	0.92	0.73	0.69	0.89	0.69	0.86	0.84	0.79	0.94	0.87	-0.91	0.89	-0.87	0.66	0.74
Total Stockholder Equity	0.87	0.69	0.72		0.59	0.96	-0.9	-0.41	0.42	0.8	0.82	0.85	0.82	0.97	0.87	0.64	0.67	0.89	0.55	0.71	0.92	-0.74	0.87	-0.8	0.74	0.88
Other Liab	0.73	0.59	0.59	0.59		0.71	-0.75	-0.01	-0.28	0.33	0.8	0.69	0.78	0.45	0.76	0.61	0.8	0.74	0.61	0.74	0.78	-0.81	0.76	-0.82	0.96	0.78
Net Tangible Assets	0.91	0.77	0.78	0.96	0.71		-0.91	-0.42	0.26	0.67	0.92	0.86	0.8	0.88	0.94	0.59	0.75	0.94	0.74	0.79	0.96	-0.81	0.94	-0.92	0.83	0.94
Property Plant And Equipment Net	-0.95	-0.86	-0.87	-0.9	-0.75	-0.91		0.06	0.0	-0.77	-0.9	-0.95	-0.85	-0.87	-0.92	-0.86	-0.92	-0.92	-0.68	-0.93	-0.98	0.95	-0.93	0.92	-0.85	-0.87
Net Debt	-0.12	-0.04	-0.07	-0.41	-0.01	-0.42	0.06		-0.77	-0.21	-0.24	-0.01	-0.14	-0.3	-0.23	0.41	0.24	-0.2	-0.22	0.13	-0.19	-0.13	-0.2	0.16	-0.04	-0.26
Retained Earnings	0.02	-0.17	-0.1	0.42	-0.28	0.26	0.0	-0.77		0.41	-0.03	-0.01	0.15	0.45	0.03	-0.26	-0.38	0.08	-0.25	-0.28	0.04	0.28	0.04	0.14	-0.16	0.11
Accounts Payable	0.66	0.61	0.67	0.8	0.33	0.67	-0.77	-0.21	0.41		0.56	0.71	0.71	0.86	0.57	0.69	0.54	0.58	0.25	0.61	0.7	-0.59	0.6	-0.53	0.41	0.5
Cash	0.96	0.91	0.91	0.82	0.8	0.92	-0.9	-0.24	-0.03	0.56		0.92	0.83	0.73	0.99	0.62	0.87	0.95	0.85	0.91	0.95	-0.92	0.98	-0.97	0.87	0.93
Non Current Assets Total	0.99	0.9	0.92	0.85	0.69	0.86	-0.95	-0.01	-0.01	0.71	0.92		0.89	0.84	0.95	0.8	0.9	0.95	0.65	0.94	0.93	-0.94	0.96	-0.87	0.81	0.89
Non Currrent Assets Other	0.88	0.68	0.73	0.82	0.78	0.8	-0.85	-0.14	0.15	0.71	0.83	0.89		0.78	0.84	0.69	0.74	0.87	0.41	0.76	0.82	-0.8	0.86	-0.74	0.85	0.85
Other Assets	0.83	0.65	0.69	0.97	0.45	0.88	-0.87	-0.3	0.45	0.86	0.73	0.84	0.78		0.8	0.69	0.64	0.84	0.43	0.68	0.86	-0.69	0.81	-0.71	0.64	0.8
Cash And Short Term Investments	0.98	0.88	0.89	0.87	0.76	0.94	-0.92	-0.23	0.03	0.57	0.99	0.95	0.84	0.8		0.64	0.86	0.99	0.81	0.9	0.96	-0.91	1.0	-0.95	0.87	0.96
Common Stock Shares Outstanding	0.74	0.68	0.69	0.64	0.61	0.59	-0.86	0.41	-0.26	0.69	0.62	0.8	0.69	0.69	0.64		0.88	0.67	0.38	0.84	0.76	-0.86	0.67	-0.68	0.69	0.59
Non Current Liabilities Total	0.89	0.88	0.86	0.67	0.8	0.75	-0.92	0.24	-0.38	0.54	0.87	0.9	0.74	0.64	0.86	0.88		0.84	0.74	0.98	0.89	-0.99	0.87	-0.91	0.85	0.78
Other Current Assets	0.98	0.82	0.84	0.89	0.74	0.94	-0.92	-0.2	0.08	0.58	0.95	0.95	0.87	0.84	0.99	0.67	0.84		0.72	0.87	0.94	-0.89	0.99	-0.91	0.88	0.98
Other Stockholder Equity	0.73	0.84	0.79	0.55	0.61	0.74	-0.68	-0.22	-0.25	0.25	0.85	0.65	0.41	0.43	0.81	0.38	0.74	0.72		0.78	0.77	-0.76	0.78	-0.89	0.64	0.69
Total Liab	0.93	0.95	0.94	0.71	0.74	0.79	-0.93	0.13	-0.28	0.61	0.91	0.94	0.76	0.68	0.9	0.84	0.98	0.87	0.78		0.91	-0.99	0.9	-0.92	0.8	0.79
Net Invested Capital	0.95	0.86	0.87	0.92	0.78	0.96	-0.98	-0.19	0.04	0.7	0.95	0.93	0.82	0.86	0.96	0.76	0.89	0.94	0.77	0.91		-0.93	0.96	-0.97	0.88	0.92
Property Plant And Equipment Gross	-0.94	-0.91	-0.91	-0.74	-0.81	-0.81	0.95	-0.13	0.28	-0.59	-0.92	-0.94	-0.8	-0.69	-0.91	-0.86	-0.99	-0.89	-0.76	-0.99	-0.93		-0.92	0.94	-0.87	-0.83
Total Current Assets	0.99	0.88	0.89	0.87	0.76	0.94	-0.93	-0.2	0.04	0.6	0.98	0.96	0.86	0.81	1.0	0.67	0.87	0.99	0.78	0.9	0.96	-0.92		-0.94	0.88	0.96
Capital Stock	-0.92	-0.89	-0.87	-0.8	-0.82	-0.92	0.92	0.16	0.14	-0.53	-0.97	-0.87	-0.74	-0.71	-0.95	-0.68	-0.91	-0.91	-0.89	-0.92	-0.97	0.94	-0.94		-0.88	-0.89
Non Current Liabilities Other	0.86	0.66	0.66	0.74	0.96	0.83	-0.85	-0.04	-0.16	0.41	0.87	0.81	0.85	0.64	0.87	0.69	0.85	0.88	0.64	0.8	0.88	-0.87	0.88	-0.88		0.92
Net Working Capital	0.94	0.73	0.74	0.88	0.78	0.94	-0.87	-0.26	0.11	0.5	0.93	0.89	0.85	0.8	0.96	0.59	0.78	0.98	0.69	0.79	0.92	-0.83	0.96	-0.89	0.92

Click cells to compare fundamentals

Harmony Biosciences Account Relationship Matchups

Harmony Biosciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	106.7M	427.1M	433.4M	673.9M	811.4M	466.0M
Other Current Liab	13.5M	132.0M	50.8M	73.1M	131.1M	74.5M
Total Current Liabilities	19.9M	134.5M	53.8M	78.9M	163.8M	84.0M
Total Stockholder Equity	(11.6M)	97.2M	186.5M	402.8M	467.0M	490.3M
Other Liab	450K	1.1M	3.2M	1.5M	1.8M	1.5M
Net Tangible Assets	(495.0M)	(65.2M)	42.6M	241.9M	278.2M	292.1M
Property Plant And Equipment Net	1.3M	938K	820K	573K	371K	352.5K
Net Debt	73.5M	(34.4M)	(42.3M)	(52.1M)	(118.1M)	(112.2M)
Retained Earnings	(422.9M)	(488.2M)	(453.6M)	(272.1M)	(143.3M)	(150.4M)
Accounts Payable	6.4M	2.6M	1.0M	3.8M	17.7M	18.6M
Cash	24.5M	228.6M	234.3M	243.8M	311.7M	206.5M
Non Current Assets Total	75.2M	164.2M	149.0M	273.6M	360.4M	187.9M
Non Currrent Assets Other	1.7M	902K	4.3M	3.5M	6.6M	3.3M
Other Assets	1.7M	902K	4.3M	87.2M	100.3M	105.3M
Cash And Short Term Investments	24.5M	228.6M	234.3M	323.1M	353.5M	228.7M
Net Receivables	4.3M	22.2M	34.8M	54.7M	74.1M	77.8M
Common Stock Shares Outstanding	63.7M	56.9M	59.2M	61.1M	60.4M	64.3M
Liabilities And Stockholders Equity	106.7M	427.1M	433.4M	673.9M	811.4M	466.0M
Non Current Liabilities Total	98.4M	195.4M	193.2M	192.1M	180.7M	157.7M
Inventory	1.1M	3.8M	4.4M	4.3M	5.4M	3.5M
Other Current Assets	261K	8.3M	10.9M	18.1M	18.1M	10.6M
Other Stockholder Equity	1K	1.0B	640.1M	675.1M	610.3M	598.1M
Total Liab	118.3M	329.9M	246.9M	271.0M	344.5M	241.7M
Net Invested Capital	(324.9M)	291.4M	378.5M	594.5M	660.6M	693.6M
Total Current Assets	31.5M	262.9M	284.4M	400.3M	451.1M	278.1M
Non Current Liabilities Other	163K	893K	3.2M	2.5M	2.1M	1.7M
Net Working Capital	11.6M	128.4M	230.7M	321.4M	287.3M	194.1M
Property Plant Equipment	1.3M	938K	820K	573K	515.7K	837.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Harmony Accounts Payable vs Capital Stock Analysis

Accounts Payable vs Capital Stock

Accounts Payable vs Capital Stock Correlation Analysis

Correlation Coefficient

Accounts Payable

Capital Stock

Harmony Biosciences fundamental ratios Correlations

Harmony Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Harmony Biosciences fundamental ratios Accounts

Also Currently Popular

Additional Tools for Harmony Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Current Assets Total	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab
Cash And Short Term Investments	+ 0.99	Cash
Other Current Assets	+ 0.99	Cash And Short Term Investments

Property Plant And Equipment Gross	- 0.99	Total Liab
Property Plant And Equipment Gross	- 0.99	Non Current Liabilities Total
Net Invested Capital	- 0.98	Property Plant And Equipment Net
Capital Stock	- 0.97	Net Invested Capital
Capital Stock	- 0.97	Cash
Capital Stock	- 0.95	Cash And Short Term Investments